Together, we can change this
NASS has launched the Gold Standard Time to Diagnosis programme and is determined to reduce the average time to diagnosis of axial SpA (AS) to just one year.
We can’t make this change alone. It’s vital that we work with the healthcare community and people living with axial SpA (AS) to build the consensus needed to make this change.
Sign-up to stay in touch and find out how you can help us ensure that thousands of people with undiagnosed axial SpA (AS) are able to live well with the condition sooner.
About the Gold Standard Time to Diagnosis programme
The Gold Standard Time to Diagnosis programme is led by the National Axial Spondyloarthritis Society (NASS) in partnership with Norfolk & Norwich NHS Foundation Trust and RUH Bath NHS Foundation Trust and is funded by UCB.
UCB (www.ucbpharma.co.uk) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases.
The Gold Standard Time to Diagnosis programme is funded by UCB as sponsor of the project. UCB is a non-voting member of the project board and has no editorial control over the content or output of the programme.
